Emily Louise Hon Castellanos, MD, MPH

Link to /sites/default/files/styles/person_photo/public/photo/castellanos-emily-headshot.jpg?h=ba3e4550&itok=RqDq3BXa

Adjunct Professor, Department of Hematology/Oncology

Specialties

  • Breast Medical Oncology

Areas of Expertise

Breast Cancer

Distinctions

Clinical Locations

  • Fox Chase Cancer Center
    333 Cottman Avenue
    Philadelphia, PA 19111
    Phone: 888-369-2427

Educational Background

  • 2018 — Masters in Public Health, Vanderbilt University School of Medicine, Nashville, Tennessee
  • 2016 — Hematology/Oncology Fellowship, Vanderbilt University Medical Center, Nashville, Tennessee
  • 2012 — Internal Medicine Residency, Vanderbilt University Medical Center, Nashville, Tennessee
  • 2009 — MD, Vanderbilt University School of Medicine, Nashville, Tennessee
  • 2007-2008 — Vanderbilt Medical Scholars Program, Vanderbilt University School of Medicine, Nashville, Tennessee
  • 2004 — BS in Biological Sciences, Stanford University, Stanford, California

Certifications

  • American Board of Internal Medicine - Internal Medicine
  • American Board of Internal Medicine - Hematology
  • American Board of Internal Medicine - Medical Oncology

Memberships

  • 2013-Present — American Society of Clinical Oncology
  • 2015-2016 — International Association for the Study of Lung Cancer
  • 2017-2018 — Tennessee Oncology Practice Society
  • 2017-2018 — Multinational Association of Supportive Care in Cancer
  • 2017-2018 — Academy Health

Honors & Awards

  • 2004 — Cap and Gown Stanford Women's Society, Stanford University
  • 2004 — Phi Beta Kappa, Stanford University
  • 2008 — Alpha Omega Alpha, Vanderbilt University School of Medicine
  • 2009 — The Endocrine Society Award for Excellence in Clinical Endocrinology, Vanderbilt University School of Medicine
  • 2014 — Medical Education Scholarship Award (MESA): Outstanding Poster by a Trainee Award, Southern Group on Education Affairs Annual Meeting, Miami, Florida
  • 2016 — AACR Scholar-in-Training Award, National Cancer Institute Center, Ninth AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, Fort Lauderdale, Florida
  • 2024 — Philadelphia Magazine Top Doctors, 2024

Selected Publications

Castellanos EH, Charboneau E, Dietrich MS, Park S, Bradley BP, Mogg K, Cowan RL. Obese Adults Have Visual Attention Bias for Food Cue Images: Evidence for Altered Reward System Function. Int J Obes (Lond). 2009 Sep;33(9):1063-73.

Castellanos EH, Chen S.C., Drexler H., Horn L. Making the Grade: The Impact of Low-grade Toxicities on Patient Preference for Treatment with Novel Agents. JNCCN. 2015 Dec;13:1490-1495.

Nikpay S, Tebbs M, Castellanos EH. Affordable Care Act Medicaid Expansions and Gains in Health Insurance Coverage and Access among Cancer Survivors. Cancer. 2018 June 15;124(12):2645-2652.

Smith DK, Castellanos EH, Murphy BA. Financial and socio-economic factors influencing pre- and post-cancer therapy oral care. Support Care Cancer. 2018 Jul;26(7):2143-2148.

Johnson DB, Nixon MJ, Wang Y, Wang DY, Castellanos E, Estrada MV, Ericsson-Gonzalez PI, Cote CH, Salgado R, Sanchez V, Dean PT, Opalenik SR, Schreeder DM, Rimm DL, Kim JY, Bordeaux J, Loi S, Horn L, Sanders ME, Ferrell PB Jr, …Balko JM. Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagement. JCI Insight. 2018;3(24):e120360. Published 2018 Dec 20.

Castellanos EH, Dietrich MS, Bond SM, et al. Impact of patient symptoms and caregiving tasks on psychological distress in caregivers for head and neck cancer (HNC). Psychooncology. 2019;28(3):511-517. doi:10.1002/pon.4968

Castellanos EH, Orlando A, Ma X, Parikh RB, O’Connell G, Meropol NJ, Hamrick J, Adamson BJ. Evaluating the Impact of Oncology Care Model Reporting Requirements on Biomarker Testing and Treatment. JCO Oncology Practice. 2020 Jun 4; JOP1900747. DOI: 10.1200/JOP.19.00747.

Madison R, Schrock AB, Castellanos E, Gregg JP, Snider J, Ali SM, Miller VA, Singal G, Alexander BM, Venstrom JM, Chung JH. Retrospective analysis of real-world data to determine clinical outcomes of patients with advanced non-small cell lung cancer following cell-free circulating tumor DNA genomic profiling. Lung Cancer. Online 2020 Aug 6.

Shao C, Li G, Huang L, Pruitt S, Castellanos E, Frampton G, Carson KR, Snow T, Singal G, Fabrizio D, Alexander BM, Jin F, Zhou W. Prevalence of High Tumor Mutational Burden and Association With Survival in Patients With Less Common Solid Tumors. JAMA Netw Open. 2020 Oct 1;3(10):e2025109.

Resize Text

Related Articles